Another study demonstrated that VIRMA downregulated the mRNA stability of the tumor suppressor RND3 through an m6A-YTHDC1-dependent mechanism, thereby suppressing its expression and exerting oncogenic effects in HCC cells [18]. This evidence concerns the gene VIRMA and hepatocellular carcinoma.